EGFR and glioblastoma: Ever since the discovery that sEVs expressing EGFRvIII from glioblastoma patients can cross the blood brain barrier and be quantified in the serum [219], the EGFR family has garnered notable attention within the EV field, bolstered by its importance as cellular biomarkers.